These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27765019)

  • 1. Impact of RNA degradation on fusion detection by RNA-seq.
    Davila JI; Fadra NM; Wang X; McDonald AM; Nair AA; Crusan BR; Wu X; Blommel JH; Jen J; Rumilla KM; Jenkins RB; Aypar U; Klee EW; Kipp BR; Halling KC
    BMC Genomics; 2016 Oct; 17(1):814. PubMed ID: 27765019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of bcr/c-abl mRNA in chronic myelogenous leukemia by polymerase chain reaction to identify chromosome translocation.
    Lin CP; Chen PM; Yen JS; Wang RL; Lee LS; Chen PH; Chang JG
    J Formos Med Assoc; 1992 Mar; 91(3):247-51. PubMed ID: 1354683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
    Yaghmaie M; Ghaffari SH; Ghavamzadeh A; Alimoghaddam K; Jahani M; Mousavi SA; Irvani M; Bahar B; Bibordi I
    Arch Iran Med; 2008 May; 11(3):247-51. PubMed ID: 18426313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias.
    Burmeister T; Gröger D; Kühn A; Hoelzer D; Thiel E; Reinhardt R
    DNA Repair (Amst); 2011 Nov; 10(11):1131-7. PubMed ID: 21944569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multiplex PCR for improved detection of typical and atypical BCR-ABL fusion transcripts.
    Burmeister T; Reinhardt R
    Leuk Res; 2008 Apr; 32(4):579-85. PubMed ID: 17928051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of library prep approaches for sequencing low input translatome samples.
    Song Y; Milon B; Ott S; Zhao X; Sadzewicz L; Shetty A; Boger ET; Tallon LJ; Morell RJ; Mahurkar A; Hertzano R
    BMC Genomics; 2018 Sep; 19(1):696. PubMed ID: 30241496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chronic myelocytic cell line K 562 contains minor (m) as well as major (M) ber/abl fusion mRNAs.
    Seelig R; Schranz P; Bottner C; Neubauer A; Seelig HP; Renz M
    Leukemia; 1993 Nov; 7(11):1886-7. PubMed ID: 8231257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
    Prejzner W
    Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of BCR/ABL variants in chronic myeloid leukemia patients using multiplex RT-PCR.
    Bennour A; Ouahchi I; Moez M; Elloumi M; Khelif A; Saad A; Sennana H
    Clin Lab; 2012; 58(5-6):433-9. PubMed ID: 22783572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid Leukemia.
    Rostami G; Hamid M; Jalaeikhoo H
    Gene; 2017 Sep; 627():202-206. PubMed ID: 28627443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
    Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM
    Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing.
    Cieslik M; Chugh R; Wu YM; Wu M; Brennan C; Lonigro R; Su F; Wang R; Siddiqui J; Mehra R; Cao X; Lucas D; Chinnaiyan AM; Robinson D
    Genome Res; 2015 Sep; 25(9):1372-81. PubMed ID: 26253700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of the breakpoint in the ABL gene in cases with BCR/ABL transcript lacking ABL exon a2.
    Iwata S; Mizutani S; Nakazawa S; Yata J
    Leukemia; 1994 Oct; 8(10):1696-702. PubMed ID: 7934165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
    Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
    Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
    Furukawa Y; Ju SL; Cho HL; Tatsumi N
    Osaka City Med J; 1993 Jun; 39(1):35-45. PubMed ID: 7694218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.
    Liu LG; Tanaka H; Ito K; Kyo T; Ito T; Kimura A
    Am J Hematol; 2003 Dec; 74(4):268-72. PubMed ID: 14635208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LightCycler technology for the quantitation of bcr/abl fusion transcripts.
    Kreuzer KA; Lass U; Bohn A; Landt O; Schmidt CA
    Cancer Res; 1999 Jul; 59(13):3171-4. PubMed ID: 10397261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic diagnosis of chronic myeloid leukemia].
    Kato C; Naoe T
    Nihon Rinsho; 2001 Dec; 59(12):2336-41. PubMed ID: 11766335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of therapeutic effects of low-dose versus high-dose interferon alpha-2b treatment on chronic myelocytic leukemia: a prospective randomized study].
    Du JW; Zhu P; Tian D; Dong ZR; Yang SL; Li SB; Tang YH; Liu H; Cen XN; Zhang Y; Zhu Q; Zhu YL; Yang Y; Wang DX; Wang Z; Cui H; Ma YG; Chen WM; Liu FQ; Ma J; Wang JW; Shen T; Da WM
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1305-9. PubMed ID: 16029627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of molecular monitoring of residual disease in leukemias by bedside RNA stabilization.
    Müller MC; Merx K; Weisser A; Kreil S; Lahaye T; Hehlmann R; Hochhaus A
    Leukemia; 2002 Dec; 16(12):2395-9. PubMed ID: 12454744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.